Azacitidine
Trade Name:
Vidaza
Manufacturer/Distributor:
Celgene
1-888-712-2353
Classification:
Antineoplastic agent
ATC Class:
L01BC07 Azacitidine
Status:
active
Notice of Compliance (yyyy/mm/dd):
2009/10/23
Date Marketed in Canada (yyyy/mm/dd):
2009/12/07
Presentation:
Injection: 100 mg/vial; DIN 02336707
Comments:
For treatment of adult patients who are not eligible for haemotopoietic stem cell transplantation with intermediate or high-risk myelodysplastic syndrome or acute myeloid leukemia.
| Posted | Updated |
|---|---|
| 2010-01-30 11:12 | 2010-01-30 11:17 |
Back to:
Drug Product Listings 
